User profiles for Rebecca G Spencer
 | Rebecca SpencerUniversity of Leeds Verified email at leeds.ac.uk Cited by 2559 |
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
…, F Griffiths, W Oosthuyzen, C Donegan, RG Spencer… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation …
…, C Hastie, C Donohue, RG Spencer… - The Lancet Regional …, 2021 - thelancet.com
Background This study sought to establish the long-term effects of Covid-19 following
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
[HTML][HTML] Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation …
Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …
[HTML][HTML] Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
Background Dexamethasone was the first intervention proven to reduce mortality in patients
with COVID-19 being treated in hospital. We aimed to evaluate the adoption of …
with COVID-19 being treated in hospital. We aimed to evaluate the adoption of …
[HTML][HTML] Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves
…, M Girvan, C Donohue, C Donegan, RG Spencer… - Pediatric …, 2023 - nature.com
Background We hypothesised that the clinical characteristics of hospitalised children and
young people (CYP) with SARS-CoV-2 in the UK second wave (W2) would differ from the first …
young people (CYP) with SARS-CoV-2 in the UK second wave (W2) would differ from the first …
Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational …
…, M Girvan, C Donohue, C Donegan, RG Spencer… - Medrxiv, 2021 - medrxiv.org
Background Children and young people (CYP) were less affected than adults in the first
wave of SARS-CoV-2 in the UK. We test the hypothesis that clinical characteristics of …
wave of SARS-CoV-2 in the UK. We test the hypothesis that clinical characteristics of …
[PDF][PDF] Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK
Background Dexamethasone was the first intervention proven to reduce mortality in patients
with COVID-19 being treated in hospital. We aimed to evaluate the adoption of …
with COVID-19 being treated in hospital. We aimed to evaluate the adoption of …
13. INSPIRE-ASP pneumonia trial: a 59 hospital cluster randomized evaluation of INtelligent Stewardship Prompts to improve real-time empiric antibiotic selection …
…, J Moody, MH Coady, GF Rebecca… - Open Forum …, 2021 - academic.oup.com
Background Up to 40% of hospitalized patients receive unnecessary or inappropriately
broad antibiotics despite a low risk of multidrug-resistant organism (MDRO) infection. Empiric …
broad antibiotics despite a low risk of multidrug-resistant organism (MDRO) infection. Empiric …
42. INSPIRE-ASP UTI trial: a 59 hospital cluster randomized evaluation of INtelligent Stewardship Prompts to improve real-time empiric antibiotic selection versus …
…, J Moody, MH Coady, GF Rebecca… - Open Forum …, 2021 - academic.oup.com
Background Up to 40% of hospitalized patients receive unnecessary or inappropriately
broad antibiotics despite a low risk of multidrug-resistant organism (MDRO) infection. Empiric …
broad antibiotics despite a low risk of multidrug-resistant organism (MDRO) infection. Empiric …
[HTML][HTML] Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
The ongoing SARS-CoV-2 pandemic was initially managed by non-pharmaceutical
interventions such as diagnostic testing, isolation of positive cases, physical distancing and …
interventions such as diagnostic testing, isolation of positive cases, physical distancing and …
